ATE318584T1 - Prozess zur herstellung kristalliner partikel von fluticason, beclomethason, salmeterol und salbutamol - Google Patents

Prozess zur herstellung kristalliner partikel von fluticason, beclomethason, salmeterol und salbutamol

Info

Publication number
ATE318584T1
ATE318584T1 AT02770107T AT02770107T ATE318584T1 AT E318584 T1 ATE318584 T1 AT E318584T1 AT 02770107 T AT02770107 T AT 02770107T AT 02770107 T AT02770107 T AT 02770107T AT E318584 T1 ATE318584 T1 AT E318584T1
Authority
AT
Austria
Prior art keywords
solvent
substance
liquid
crystalline particles
beclomethason
Prior art date
Application number
AT02770107T
Other languages
English (en)
Inventor
Martin John Mcloughlin
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ATE318584T1 publication Critical patent/ATE318584T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Extraction Or Liquid Replacement (AREA)
  • Mixers With Rotating Receptacles And Mixers With Vibration Mechanisms (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Catalysts (AREA)
  • Saccharide Compounds (AREA)
AT02770107T 2001-10-25 2002-10-23 Prozess zur herstellung kristalliner partikel von fluticason, beclomethason, salmeterol und salbutamol ATE318584T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0125604.9A GB0125604D0 (en) 2001-10-25 2001-10-25 Novel process

Publications (1)

Publication Number Publication Date
ATE318584T1 true ATE318584T1 (de) 2006-03-15

Family

ID=9924497

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02770107T ATE318584T1 (de) 2001-10-25 2002-10-23 Prozess zur herstellung kristalliner partikel von fluticason, beclomethason, salmeterol und salbutamol

Country Status (8)

Country Link
US (1) US20040258756A1 (de)
EP (1) EP1438023B1 (de)
JP (1) JP4351532B2 (de)
AT (1) ATE318584T1 (de)
DE (1) DE60209516T2 (de)
ES (1) ES2258156T3 (de)
GB (1) GB0125604D0 (de)
WO (1) WO2003035035A1 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0216700D0 (en) 2002-07-18 2002-08-28 Astrazeneca Ab Process
GB0302673D0 (en) 2003-02-06 2003-03-12 Astrazeneca Ab Pharmaceutical formulations
SE0302029D0 (sv) * 2003-07-07 2003-07-07 Astrazeneca Ab Novel process
JP2005177746A (ja) * 2003-11-28 2005-07-07 Mitsubishi Chemicals Corp 有機化合物微粒子の製造方法
GB0406069D0 (en) * 2004-03-17 2004-04-21 Thompson James Process
WO2006096906A1 (en) * 2005-03-18 2006-09-21 Nanomaterials Technology Pte Ltd Inhalable drug
JP4896418B2 (ja) * 2005-03-23 2012-03-14 富士フイルム株式会社 有機微粒子およびその分散液の製造方法、ならびにそれにより得られる有機微粒子およびその分散液
EP1868577A4 (de) 2005-04-15 2009-12-09 Reddys Lab Inc Dr Lacidipin-partikel
US8679341B2 (en) * 2005-05-06 2014-03-25 Fujifilm Corporation Method of concentrating nanoparticles and method of deaggregating aggregated nanoparticles
JP4870383B2 (ja) * 2005-05-06 2012-02-08 富士フイルム株式会社 ナノ粒子の濃縮方法
JP4993875B2 (ja) * 2005-05-06 2012-08-08 富士フイルム株式会社 凝集ナノ粒子の分散方法
US8283395B2 (en) 2005-05-09 2012-10-09 Fujifilm Corporation Method of producing organic-particles-dispersion liquid
FR2897267A1 (fr) * 2006-02-16 2007-08-17 Flamel Technologies Sa Formes pharmaceutiques multimicroparticulaires pour administration per os
GB0705159D0 (en) 2007-03-19 2007-04-25 Prosonix Ltd Process for making crystals
GB0711680D0 (en) * 2007-06-18 2007-07-25 Prosonix Ltd Process
US8052645B2 (en) 2008-07-23 2011-11-08 Avant Medical Corp. System and method for an injection using a syringe needle
US9974904B2 (en) 2008-05-20 2018-05-22 Avant Medical Corp. Autoinjector system
PT105058B (pt) * 2010-04-21 2013-04-17 Hovione Farmaciencia S A Processo para processamento de partículas de ingredientes activos farmacêuticos
CN102058996A (zh) * 2010-10-29 2011-05-18 华侨大学 非溶剂法改进超临界抗溶剂过程制备药物超细微粒的方法
HUE042822T2 (hu) 2011-04-20 2019-07-29 Amgen Inc Automata befecskendezõ szerkezet
AU2012282936B2 (en) * 2011-07-08 2016-11-10 Pfizer Limited Process for the preparation of fluticasone propionate form 1
USD898908S1 (en) 2012-04-20 2020-10-13 Amgen Inc. Pharmaceutical product cassette for an injection device
US8765725B2 (en) 2012-05-08 2014-07-01 Aciex Therapeutics, Inc. Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof
EP2847207B1 (de) 2012-05-08 2019-03-27 Nicox Ophthalmics, Inc. Nanokristalle von Fluticasonpropionat
EP2705838A1 (de) * 2012-09-06 2014-03-12 Xspray Microparticles Ab Tiotropium-Zubereitungen
DE102012221219B4 (de) * 2012-11-20 2014-05-28 Jesalis Pharma Gmbh Verfahren zur Vergrößerung der Partikelgröße kristalliner Wirkstoff-Mikropartikel
US9815865B2 (en) 2013-01-07 2017-11-14 Nicox Ophthalmics, Inc. Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof
US9855538B2 (en) 2013-03-08 2018-01-02 The Board Of Trustees Of The University Of Illinois Ultrasonic method and apparatus for producing particles having a controlled size distribution
TWI614041B (zh) 2013-03-15 2018-02-11 安美基公司 用於注射器之匣盒
JP6336564B2 (ja) 2013-03-15 2018-06-06 アムゲン・インコーポレーテッド 薬物カセット、自動注入器、および自動注入器システム
CN104055741B (zh) * 2013-03-18 2017-02-15 青岛大学 一种孟鲁司特钠片剂及其制备方法
GB201402556D0 (en) 2014-02-13 2014-04-02 Crystec Ltd Improvements relating to inhalable particles
CN104771931B (zh) * 2015-04-20 2016-12-07 顾玉奎 一种中药超声提取装置

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4855436A (en) * 1987-12-11 1989-08-08 Jet Research Center, Inc. Method of preparation of 2,6-bis(picrylamino)-3,5-dinitropyridine
ES2078447T3 (es) * 1990-06-15 1995-12-16 Merck & Co Inc Un procedimiento de cristalizacion para mejorar la estructura y el tamaño de los cristales.
FR2669635B1 (fr) * 1990-11-22 1994-06-10 Furchim Procede de fabrication d'hydroxymethylfurfural (hmf) du purete elevee.
US5658549A (en) * 1991-12-12 1997-08-19 Glaxo Group Limited Aerosol formulations containing propellant 134a and fluticasone propionate
GB9610821D0 (en) * 1996-05-23 1996-07-31 Glaxo Wellcome Inc Metering apparatus
GB9622173D0 (en) * 1996-10-24 1996-12-18 Glaxo Group Ltd Particulate Products
GB9828721D0 (en) * 1998-12-24 1999-02-17 Glaxo Group Ltd Novel apparatus and process
GB9925934D0 (en) * 1999-11-03 1999-12-29 Glaxo Group Ltd Novel apparatus and process

Also Published As

Publication number Publication date
JP4351532B2 (ja) 2009-10-28
DE60209516D1 (de) 2006-04-27
GB0125604D0 (en) 2001-12-19
EP1438023A1 (de) 2004-07-21
US20040258756A1 (en) 2004-12-23
EP1438023B1 (de) 2006-03-01
ES2258156T3 (es) 2006-08-16
DE60209516T2 (de) 2006-08-10
JP2005512763A (ja) 2005-05-12
WO2003035035A1 (en) 2003-05-01

Similar Documents

Publication Publication Date Title
ATE318584T1 (de) Prozess zur herstellung kristalliner partikel von fluticason, beclomethason, salmeterol und salbutamol
ATE296315T1 (de) Galactosylierte glykoproteine enthaltende zusammensetzungen und verfahren zur deren herstellung
SE8403427L (sv) Sett att framstella buten - l
ATE364060T1 (de) Mikroporöse materialien und verfahren zu ihrer herstellung
ES542483A0 (es) Procedimiento de preparacion de una forma galenica para ad- ministracion por via oral
WO2006055817A3 (en) Mixed matrix membrane with mesoporous particles and methods for making the same
RU2009138325A (ru) Способ получения кристаллов
DE60021098D1 (de) Von isoagglutinin befreite blutzusammensetzungen und verfahren zu ihrer herstellung
DE69510937D1 (de) Verfahren zur gewinnung von polyhydroxyalkanoaten mittels zentrifugenfraktionerung
DE502004007677D1 (de) Verfahren zur herstellung von propylenoxid
ATE440503T1 (de) Verfahren zur herstellung von einem monodispersen schaum , und dadurch hergestelltes produkt
WO2002002738A3 (en) Host cells containing multiple integrating vectors
ATE332297T1 (de) Verfahren zur herstellung von ascorbinsäure
ATE421339T1 (de) Vereinfachte methode zur entfernung von freiem protein während der herstellung von protein- polysaccharid-konjugaten und impfstoffen unter verwendung von medien mit limitierter durchlässigkeit
DE69927602D1 (de) Verfahren zur herstellung von vitaminpulvern
WO2002022228A3 (en) Method for fractionating liquid mixtures
ATE279414T1 (de) Verfahren zur herstellung von reinem triethylendiamin (teda)
DE50107344D1 (de) Herstellung von polygalakturoniden und ihre verwendung als lebensmittelzusatzstoffe
SE9603304D0 (sv) Process for purifying a compound
ATE92075T1 (de) Verfahren zur gewinnung aktiver proteine aus einer biologisch inaktiven form.
ATE222920T1 (de) Ein kristall von diuridine tetraphosphat oder ein solches salz und verfahren zu seiner herstellung, verfahren und herstellung der vorgenannten zusammensetzung
EP1591473A4 (de) Poröse teilchen und kosmetika
RU95112488A (ru) Способ выделения энантиомеров из рацемической смеси
PE20050430A1 (es) Metodo para preparar un extracto de hojas de hiedra y extracto preparado segun este metodo
ATE235259T1 (de) Verfahren zur herstellung von kontrastmitteln

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties